FDA wants cannabis products added to adverse event form (Newsletter: January 23, 2025)
Trump’s first drug war pardon; PA legalization chances; CO & VA psychedelics votes; Poll: More Americans use cannabis as a sleep aid than Rx pills Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Your support makes […]
FDA Wants To Add Hemp-Derived Cannabinoid Product Option To Federal Form About Negative Consumer Experiences
In an effort to better track the health impacts of hemp-derived cannabinoid products in the U.S., the Food and Drug Administration (FDA) is proposing that CBD and other hemp-derived cannabinoids be added as selectable options on federal documents used by healthcare professionals, patients and consumers to report adverse events. Published on Friday in a Federal […]
FDA Seeks Veterinarians’ Input On Use Of CBD And Other Cannabis Products In Animals
The Food and Drug Administration is asking for comments from veterinarians and the broader public about the use of cannabis-derived products—in particular CBD—in animals. The agency wants to know more about usage trends, potential drug interactions, quality standards and other issues related to the veterinary use of cannabinoids. The comment period opens on Thursday and […]
Cannabis Analyzer Chosen by FDA for Quick, Accurate Product Testing
The U.S. Food and Drug Administration (FDA) announced on Aug. 18 that it has chosen a very specific company’s portable cannabis analyzer to be used to test cannabis plants as well as products. The analyzer was created by Orange Photonics, which utilizes spectroscopy and liquid chromatography in its LightLab 3 High Sensitivity (HS) Cannabis Analyzer. […]
House Panel Calls On FDA To Regulate CBD For Foods, Beverages
Hemp advocates and industry leaders last week called on the federal government to ease access to cannabidiol as a House of Representatives subcommittee held a hearing to investigate the U.S. Food and Drug Administration’s refusal to regulate CBD as an ingredient in foods, beverages and dietary supplements. At Thursday’s hearing of the House Oversight and […]
FDA Issues Draft Guidance For Clinical Studies On Psychedelics
The United States Food and Drug Administration, aka the FDA, issued the first-ever guidance for clinical studies on psychedelics, according to a news release issued Friday. They filed the 14-page document shortly after Congress introduced bipartisan legislation led by Texas Republican Representative Dan Crenshaw, directing the issuance of clinical trial guidelines. They aimed the guidance […]